Il libro è attualmente esaurito

Maggiori informazioni sul libro
From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M& A) and in-licensings in the pharmaceutical industry between 1998 and 2012. Utilizing the event study methodology, the volume shows that M& A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. But what are the underlying value drivers which make a deal a success or a failure story? The author derives significant innovative determinants of success for both strategies.
Acquisto del libro
Pharma m&a versus alliances and its underlying value drivers, Heiko Schon
- Lingua
- Pubblicato
- 2015
- product-detail.submit-box.info.binding
- (Copertina rigida)
Ti avviseremo via email non appena lo rintracceremo.
Metodi di pagamento
Ancora nessuna valutazione.